Evidence map›Paper›PMID 29490663›Full record

ArticleBMC medicine2018

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.

José M Benito, María C Ortiz, Agathe León, Luis A Sarabia, José M Ligos, María Montoya, Marcial Garcia, Ezequiel Ruiz-Mateos, Rosario Palacios, Alfonso Cabello and 10 more

Abstract read
In one paragraph

Article in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Elevated Expression of miR-19b Enhances CD8Frontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

José M BenitoIIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos, 2, 28040, Madrid, Spain. jbenito1@hotmail.com.
María C OrtizUniversidad de Burgos, Burgos, Spain.
Agathe LeónHospital Clinic-IDIBAPS, HIVACAT, Universidad de Barcelona, Barcelona, Spain.
Luis A SarabiaUniversidad de Burgos, Burgos, Spain.
José M LigosCentro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
María MontoyaCentro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Marcial GarciaIIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos, 2, 28040, Madrid, Spain.
Ezequiel Ruiz-MateosHospital Virgen del Rocío, Sevilla, Spain.
Rosario PalaciosUnidad de E. Infecciosas. Hospital Virgen de la Victoria e IBIMA, Málaga, Spain.
Alfonso CabelloHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Clara RestrepoIIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos, 2, 28040, Madrid, Spain.
Carmen RodriguezCentro Sanitario Sandoval, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Jorge Del RomeroCentro Sanitario Sandoval, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Manuel LealHospital Virgen del Rocío, Sevilla, Spain.
María A Muñoz-FernándezLaboratory of Molecular Immuno-Biology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
José AlcamíAIDS Immunopathology Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Felipe GarcíaHospital Clinic-IDIBAPS, HIVACAT, Universidad de Barcelona, Barcelona, Spain.
Miguel GórgolasHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Norma RallónIIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos, 2, 28040, Madrid, Spain. normaibon@yahoo.com.
ECRIS integrated in the Spanish AIDS Research Network

Funding

ISCIII CP14/00198
6 · The paper itself

Abstract

backgroundDespite long-lasting HIV replication control, a significant proportion of elite controller (EC) patients may experience CD4 T-cell loss. Discovering perturbations in immunological parameters could help our understanding of the mechanisms that may be operating in those patients experiencing loss of immunological control.

methodsA case-control study was performed to evaluate if alterations in different T-cell homeostatic parameters can predict CD4 T-cell loss in ECs by comparing data from EC patients showing significant CD4 decline (cases) and EC patients showing stable CD4 counts (controls). The partial least-squares-class modeling (PLS-CM) statistical methodology was employed to discriminate between the two groups of patients, and as a predictive model.

resultsHerein, we show that among T-cell homeostatic alterations, lower levels of naïve and recent thymic emigrant subsets of CD8 cells and higher levels of effector and senescent subsets of CD8 cells as well as higher levels of exhaustion of CD4 cells, measured prior to CD4 T-cell loss, predict the loss of immunological control.

conclusionsThese data indicate that the parameters of T-cell homeostasis may identify those EC patients with a higher proclivity to CD4 T-cell loss. Our results may open new avenues for understanding the mechanisms underlying immunological progression despite HIV replication control, and eventually, for finding a functional cure through immune-based clinical trials.

Indexed as

HomeostasisAdultCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease ProgressionFemaleHIV InfectionsHumansMaleMiddle AgedCD4 T-cell lossCD8 exhaustionClass modelingElite controllersT-cell homeostatic parameters

Identifiers

PMID29490663
PMCPMC5830067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.